Advertisement
Trending - Altmetric
-
In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease
-
Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease
-
MicroRNAs regulation in Parkinson’s disease, and their potential role as diagnostic and therapeutic targets
-
Single-cell RNA sequencing reveals peripheral immunological features in Parkinson’s Disease